Search results
- Open0.0000Low0.0000High0.0000
- Prev. Close4.2810VolN/AAvg. VolN/A
- Mkt CapN/A52 Wk. Low0.000052 Wk. High4.9970
Related stocks
5 days ago · TNX-102 SL is for the management of fibromyalgia. Its CNS portfolio includes TNX-1300 (cocaine esterase), a biologic designed to treat cocaine intoxication that has a therapy designation.
- TONIX PHARMACEUTICALS
Research Tonix Pharmaceuticals Holding's (Nasdaq:TNXP) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more.
3 days ago · Company profile for Tonix Pharmaceuticals Holding Corp. (TNXP) with a description, list of executives, contact details and other key facts.
May 31, 2024 · With Tonix Pharmaceuticals Holding stock trading at $0.16 per share, the total value of Tonix Pharmaceuticals Holding stock (market capitalization) is $15.57M. Tonix Pharmaceuticals Holding stock was originally listed at a price of $30,000.00 in May 10, 2012.
2 days ago · Should You Buy or Sell Tonix Pharmaceuticals Stock? Get The Latest TNXP Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat.
- (862) 799-8599
- 509 MADISON AVENUE SUITE 1608, NEW YORK NY, 10022
- investor.relations@tonixpharma.com
May 31, 2024 · See the latest Tonix Pharmaceuticals Holding Corp stock price (TNXP:XNAS), related news, valuation, dividends and more to help you make your investing decisions.
People also ask
What are TNXP share price targets?
Is Tonix Pharmaceuticals (TNXP) a good growth stock for 2024?
What is the dividend yield for TXN?
What is Tonix Pharmaceuticals Holding (TNXP) market cap?
May 31, 2024 · Key information. 6.9% Earnings growth rate. 74.6% EPS growth rate. Recent future growth updates. Price target decreased to US$2.63. Mar 12. Show all updates. Earnings and Revenue Growth Forecasts. Show more. Analyst Future Growth Forecasts. Earnings vs Savings Rate: TNXP is forecast to remain unprofitable over the next 3 years.